IFPMA

Home About IFPMA Members IFPMA Code IFPMA Code Publications


IFPMA Administration and Objectives


IFPMA was created in 1968 as a non-profit, non-governmental organisation (NGO) and has since achieved consultative status with many United Nations and other international organisations. The Federation was admitted into official relations with the World Health Organization (WHO) in 1971 and is also on the NGO rosta for the World Intellectual Property Organization (WIPO), the United Nations Conference on Trade and Development (UNCTAD), the United Nations Industrial Development Organization (UNIDO), the United Nations Economic and Social Council (ECOSOC), the United Nations Children's Fund (UNICEF) and the Council of Europe.


The governing bodies of IFPMA are the Assembly and Council and the day-to-day work is carried out by the IFPMA Secretariat.

The IFPMA Assembly brings Member Associations together every two years for a formal Statutory meeting and the opportunity is taken to organise a major International Conference at the time of the Assembly.

The IFPMA Council meets three times a year. Of thirteen Council seats, nine are filled by Member Associations on a permanent basis. Four are assigned to smaller Associations on a rotating basis. Associations not represented on the Council are invited to attend meetings as observers. The Council appoints the special Advisory Committees that help carry out the work of IFPMA.

Directors of IFPMA Member Associations also meet three times a year.

The IFPMA Secretariat, based in Geneva, Switzerland, consists of a small, permanent staff headed by the Executive Vice President appointed by the Assembly.

The IFPMA Statutes set out the conditions for membership of IFPMA including evidence that the association is well established, represents a significant part of the pharmaceutical industry in the country, that its members adhere to good manufacturing practices and that they accept the provisions of the IFPMA Code of Pharmaceutical Marketing Practices.

Advisory Committees have been established on patent protection (Intellectual Protection Steering Committee), on public affairs (Public Affairs Committee) and on biological and biotechnological Products (Biologicals Committee). Other scientific matters are referred, for advice, to a panel of Scientific Coordinators within the IFPMA Member Associations. Ad hoc groups are convened when required, to undertake specific tasks, such as the preparation of publications and symposia.


Objectives

The objectives of the Federation, as set out in the Article 3 of the IFPMA Statutes are to:


IFPMA Assembly

The Assembly is responsible for the admission of new members, for the election of a President and two Vice Presidents (from members of the Council), for amendments to IFPMA Statutes and the IFPMA Code and, in general, for determination of IFPMA policies.

The President and two Vice Presidents are elected for two years, at the time of the Assembly.

The 18th IFPMA Assembly will take place in Vienna, Austria, 9-11 October 1996 when the Theme will be Emerging Healthcare Systems in Central and Eastern Europe:

Return to top


IFPMA Council

PRESIDENT

Mr Séan Lance
UK*

Managing Director
Glaxo Wellcome

VICE PRESIDENTS

Mr Lodewijk J.R. de Vink
USA*

President and Chief Operating Officer
Warner-Lambert Company

Mr Tadashi Suzuki
Japan*

President and Chief Executive Officer
Daiichi Pharmaceutical Co., Ltd.

MEMBERS

Dr Claudio Cavazza
Italy*

President
Sigma Tao S.p.A.

Professor Vanida Chitman
Thailand

Executive Director
Pharmaceutical Producers Association - PPA

The Honourable Judith A. Erola
Canada

President
Pharmaceutical Manufacturers Association of Canada - PMAC

Dr Philippe Le Goff
Switzerland

Head of Strategy and Pharma Policy
Ciba-Geigy Limited

Mr Alan F. Holmer
USA*

President
Pharmaceutical Research and Manufacturers of America - PhRMA

Dr. Hakan Mandahl
Sweden

Deputy Managing Director
Lakemedelsindustriforeningen - LIF

Mr Bernard Mesuré
France*

President
Sandoz, France

Mr Ley S. Smith
USA*

Executive Vice President
Pharmacia & Upjohn Inc

Prof Hans Rüdiger Vogel
Germany*

Hauptgeschäftsführer
Bundesverband, der Pharmazeutischen Industrie - BPI

Mrs Mirryena T. Deeb
South Africa*

Chief Executive Officer
Pharmaceutical Manufacturers Association of South Africa - PMASA

*Countries with permanent seats on Council

IFPMA Secretariat

Executive Vice President:

Dr Richard Arnold
r.arnold@ifpma.org.

Vice President for Scientific Affairs:

Miss Margaret Cone
m.cone@ifpma.org.

Director of Public Affairs:

Mr Jean-François Gaulis
j-f.gaulis@ifpma.org.

Scientific Executive:

Dr Odette Morin
o.morin@ifpma.org.

Finance and Administrative Manager:

Mr Laurent Renaud
l.renaud@ifpma.org

Personal Assistant to the EVP and Meetings Coordinator

Mrs Ruby Weber-Acosta
r.weber@ifpma.org

Public Affairs Assistant

Mrs Christine Asani (née Sherwood)
c.asani@ifpma.org

Secretary:

Mrs France Redard (née Garnier)
f.redard@ifpma.org

ICH Secretariat

The Secretariat for the International Conference on Harmonisation (ICH) operates out of the IFPMA offices and is run by Margaret Cone, Vice President for Scientific Affairs, IFPMA. The ICH staff are:

ICH Executive Officer:

Mr Katsuji Sato
k.sato@ifpma.org

Secretary (part time):

Mrs Sarah Préperier

The ICH Secretariat may be contacted by e-mail at ich@ifpma.org
We invite you to visit the ICH web pages ICH

Return to top


<Home > <About IFPMA > <Members > <IFPMA Code > <WHO > <Publications >


Copyright©1996 International Federation of Pharmaceutical Manufacturers Associations